Scaffold-Aware Generative Augmentation and Reranking for Enhanced Virtual Screening
Xin Wang, Yu Wang, Yunchao Liu, Jens Meiler, Tyler Derr · 2025
Read Scaffold-Aware Generative Augmentation and Reranking for Enhanced Virtual Screening by Xin Wang, Yu Wang, Yunchao Liu, Jens Meiler, Tyler Derr (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2510-16306.txt.
Introduction
Xin Wang and four co-authors improve virtual screening, the computational sieve drug hunters pour chemical libraries through. Screening struggles with three problems at once: active compounds are rare, a few molecular scaffolds dominate the actives, and finding structurally fresh hits matters most for new drugs.
Their framework, ScaffAug, generates synthetic training compounds with a graph diffusion model conditioned on real hit scaffolds, sampling extra data for underrepresented scaffolds to rebalance both class and structure. A self-training module then folds the synthetic data in safely, and a reranking step promotes scaffold diversity among the top recommendations. Experiments across five target classes, with ablations of each module, show gains over existing baselines in both accuracy and diversity of suggested molecules.
Catalog record
| CREATOR | Xin Wang, Yu Wang, Yunchao Liu, Jens Meiler, Tyler Derr |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2510-16306
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Scaffold-Aware Generative Augmentation and Reranking for Enhanced Virtual Screening Xin Wang, Yu Wang, Yunchao Liu, Jens Meiler, Tyler Derr Abstract Ligand-based virtual screening (VS) is an essential step in drug discovery that evaluates large chemical libraries to identify compounds that potentially bind to a therapeutic target. However, VS faces three major challenges: class imbalance due to the low active rate, structural imbalance among active molecules where certain scaffolds dominate, and the need to identify structurally diverse active compounds for novel drug development. We introduce ScaffAug , a scaffold-aware VS framework that addresses these challenges through three modules. The augmentation module first generates synthetic data conditioned on scaffolds of actual hits using generative AI, specifically a graph diffusion model. This helps mitigate the class imbalance and furthermore the structural imbalance, due to our proposed scaffold-aware sampling algorithm, designed to produce more samples for active molecules with underrepresented scaffolds. A model-agnostic self-training module is then used to safely integrate the generated synthetic data from our augmentation module with the original labeled data. Lastly, we introduce a reranking module that improves VS by enhancing scaffold diversity in the top recommended set of molecules, while still maintaining and even enhancing the overall general performance of identifying novel, active compounds. We conduct comprehensive computational experiments across five target classes, comparing ScaffAug against existing baseline methods by reporting the performance of multiple evaluation metrics and performing ablation studies on ScaffAug. Overall, this work introduces novel perspectives on effectively enhancing VS by leveraging generative augmentations, reranking, and general scaffold-awareness. 1 Introduction Virtual screening (VS) supports traditional drug discovery through computational identification of promising compounds for experimental validation, reducing time, cost, and labor ( Leelananda & Lindert 2016 ) . A fundamental task in VS involves predicting the biological activity of chemical compounds against specific therapeutic targets based on their molecular structures. Recent advances in deep learning methods, particularly graph neural networks (GNNs), have significantly improved the effectiveness of these predictive tasks ( Golkov et al. 2020 ) . However, three key challenges remain. The first challenge is class imbalance , which occurs because large libraries of molecules are tested in high-throughput screening (HTS), but only a small percentage are actual actives ( Zhu et al. 2013 ) . This means limited known, active molecules are available for reference, making model training difficult and biasing predictions toward the far more numerous inactive molecules. The second challenge is structural imbalance among known active molecules in the training data. This imbalance among known active molecules is commonly observed in VS datasets like WelQrate ( Liu et al. 2024b ) , where some groups of similar active molecules form dominant clusters. Meanwhile, many other active molecules possess structures significantly different from those in the clusters, making them underrepresented in the data. As a result, models become biased toward dominant structural clusters, potentially overlooking novel candidates with distinct molecular structures. The third challenge arises from the requirement in actual drug discovery applications to discover novel molecules distinct from existing patented structures. To increase the probability of finding novel active compounds across different regions of chemical space, medicinal chemists maximize scaffold diversity when constructing compound libraries for HTS ( Langdon et al. 2011 ) and creating virtual screening libraries ( Krier et al. 2006 ) . This involves clustering molecules based on their core structures (scaffolds) and selecting representative compounds from each cluster, with protocols like DEKOIS 2.0 ( Bauer et al. 2013 ) , which selects the most potent compound from distinct structural clusters. Deep learning models often struggle to identify novel active molecules because they tend to overfit and prioritize compounds with structural features similar to active molecules in the training data, rather than recognizing diverse structural patterns that may still produce biological activity. We propose to leverage synthetic data generation ( Lu et al. 2023 ) through generative AI, specifically a graph diffusion model ( Vignac et al. 2022 ) for small molecules to address both class and structural imbalance challenges. This method creates new samples conditioned on known active molecules’ scaffolds to generate likely active compounds, effectively balancing the representation of active versus inactive molecules in the training data. By directing the generation process toward underrepresented molecular scaffolds via our proposed scaffold-aware sampling, we produce sufficient samples that ensure adequate representation of minor structural families, enabling models to learn more comprehensive structure-activity relationships beyond dominant structural clusters. We note that this approach overcomes the inherent challenges of directly generating molecules and instead integrates the benefits of molecular generation into our enhanced virtual screening framework. To tackle the third challenge of discovering novel molecules, we design a reranking algorithm that injects scaffold diversity consideration into deep learning model’s top prediction set output. This approach helps identify promising candidates with structural novelty that models’ predicted activity scores might otherwise overlook. Specifically, we introduce ScaffAug , a novel scaffold-aware generative augmentation and reranking framework that consists of three modules to tackle the above three challenges. We demonstrate that ScaffAug significantly outperforms prior baselines across diverse VS tasks, as shown in Figure 1 . • In the augmentation module, we employ two key steps: a scaffold-aware sampling(SAS) strategy to address structural imbalances among known active molecules and build a scaffold library, and scaffold extension using a graph diffusion model (GDM) ( Vignac et al. 2022 ) that generates novel molecules while preserving the core scaffold structures in the library. The resulting generative diverse scaffold-augmented(G-DSA) dataset is then used for the training module. • The model-agnostic self-training module safely combines the augmentation dataset with the original labeled data with a pseudo-labeling strategy. An illustrative comparison with baselines is shown in Fig. 1 , while the full experimental results are presented in Section 4 . • In the reranking module, we apply Maximal Marginal Relevance (MMR) ( Carbonell & Goldstein 1998 ) to encourage scaffold diversity in the model’s top predicted set. This approach balances the model’s predicted scores with a diversity score, reranking the list to achieve higher scaffold diversity while maintaining screening quality. The rest of the paper is organized as follows. In Section 2 , we introduce preliminaries covering problem definition, notations, and related work. Thereafter, we present our proposed ScaffAug framework in Section 3 . Our experimental setup, including datasets, baseline methods, and evaluation metrics are presented in Section 4 . Then, Section 5 discusses the main experimental results, along with ablation studies and limitations. Lastly, we conclude in Section 6 . Figure 1: Representative overview of ScaffAug’s performance compared to established baseline methods on benchmark datasets. The figure highlights improvements achieved through our scaffold-aware augmentation and reranking framework. Comprehensive experimental analyses, including additional metrics and ablation studies, are presented in Section 4 . 2 Preliminaries 2.1 Problem Definition: Ligand-based Virtual Screening Ligand-based virtual screening(VS) identifies potential drug candidates from a large molecule library. We represent molecules as 2D graphs \mathcal{G} , where nodes and edges are defined by categorical attributes in spaces \mathcal{X} and \mathcal{E} with cardinalities |\mathcal{X}|=a and |\mathcal{E}|=b . The values a and b correspond to the number of atom types (e.g., carbon) and bond types (e.g., single bond) considered. We denote the attribute of node i by x_{i}\in\mathbb{R}^{a} , which is the one-hot encoding of its node